Across the pond...Nasdaq: KZIA, page-188

First 188 Last

Share
Profile

Follow
needle

2,082 Posts.

1651

10/08/20

21:55

Post #: 46437590
Share

Originally posted by needle ↑

Well there you go....there will be some sort of data from PB.. Lets hope the Kazia drug gets a strong mention.

From the big gapping this stock does....it is understandable, traders, investors look for dates of announcements

USAAbstractOur understanding of how intracranial metastases genetically evolve from the primary tumors continues to be limited. In this presentation, I will present data from large-scale genomic efforts to characterize central nervous system metastases. We demonstrated that intracranial metastases have branched evolution, whereby the brain metastases and primary tumors shared a common ancestor yet both the primary tumor and brain metastasis continued to evolve independently. This implies that precision oncology approaches based on genetic characterization of primary tumors may be suboptimal for identification of therapeutic targets from which brain metastasis patients might benefit. We also show that comprehensive genomic characterization of brain metastases can lead to the discovery of putative metastatic drivers. Importantly, despite significant genetic divergence between the brain metastases and extracranial sites, there are common clinically actionable genetic alterations across brain metastases which have therapeutic potential. These data have now been translated to a NCI-sponsored cooperative group genomically-guided clinical trial (Alliance A071701)

Expand

Unless the company has full details of what is going to be presented, and they consider it non sensitive....to be presented I think....early AM Sat our time, they will need to put the company into a halt. Probably at close of business here in Oz. 4.10pm Sydney time.

Obviously because the US will still be trading. Remember that chaotic trading when results of the first 8 patients was accidently released in late 2019.

PB

"In this presentation,
I will present data from large-scale genomic efforts to characterize central nervous system metastases. "

KZA Price at posting: 75.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Making money: How many microcaps should be in an investor's portfolio?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

What each US election outcome would mean for Australian companies & investors

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?